Although data in CCA are lacking, in breast cancer, VEGFR-3-positive TAMs are able to secrete VEGF-C and stimulate tumor lymphangiogenesis and lung metastasis of tumor cells in orthotopically implanted BALB/c and CB.17 SCID mice once selected by treatment with paclitaxel [54]. Here, FLT4 is linked to neoplasm.